Clinical Trial Update: De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE) [NA]

View source ↗

Summary

A clinical trial (DE-RADIATE) is investigating de-escalation of radiation dose for HPV-positive oropharyngeal squamous cell carcinoma guided by FMISO PET imagin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-positive Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Royal North Shore Hospital | Conditions: HPV Positive Oropharyngeal Squamous Cell Carcinoma | NA | Status: RECRUITING